All Episodes

Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency

Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment

Strategic Intent: The Rise Of Mid-Cap Dealmakers

Building The GLP-1 Companion Category, With Beverley Law And Martina Gripp

Drug Fix: Understanding The PDUFA VIII Revenue Cut And GDUFA IV Name Change

The State of Play in Biotech and the Decisions Shaping the Industry

Strategic Intent: First-in-class, two markets: Annexon’s GBS and GA Strategies

Drug Fix: Regulatory Nationalism And US FDA’s IND Reforms

Proof of Concept - AI in Drug Discovery

Digital Health Roundup: CE Mark For Vision-Restoring Implant, AI Chatbot Rules, MS Deal

Podcast: China's Evolving Role in Global Clinical Development

Off-Patent, On Record: View Through The Journalist's Lens With Generics Bulletin's Dave Wallace

Realising Growth Through Pharmacy, With Simon-Kucher’s Christian Danelund And Chris Rebholz

European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast

The Next Era Of Oncology Biosimilars

How ElevateBio Is Betting On Every Gene Editing Modality At Once

The Generics Bulletin Podcast: Summer Conferences

Drug Fix: US FDA Undoes Podium Policy, Lessons From CDC, ASPR Confirmation Hearings

Eisai Video Interview AT AAIC Alzheimer's Conference, July 15

Scrip Deals Podcast, July 2026, with Dr. Bruce Leuchter

The Dos And Don’ts Of Health Literacy, With Self-Care Forum’s Trevor Gore

Drug Fix: New Complete Response Letter, DTC Ad Regulations And A Potential US FDA Reorg

Tonix’s Bet On Monoclonal Prevention Of Lyme Disease

Patient Capital And Regulatory Resolve: Dr Reddy’s Chief On Building India's Innovation Backbone

China’s New Data Protection Framework: Periods And Impact

The Economic and Social Value Of Probiotics, With IPA Europe’s Rosanna Pecere

‘빅 드럭’ 시대 본격화…글로벌 제약 매출, 2조 달러 넘을 듯 (Korean-language podcast) June 29, 2026

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 29, 2026

Scrip's Five Must-Know Things - June 29, 2026

Drug Fix: US FDA’s New Guidance On One-Trial Efficacy Standard And IND Reform Pilot

Elevate Clinical Operations into a Board Level Strategic Advantage

The Insight Room: Catching the Deadliest Cancer Earlier - Inside the PRECEDE–Azenta Partnership

The Yescarta Launch Examined

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 22, 2026

Scrip's Five Must-Know Things - June 22, 2026

The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin

Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model

The Socio-Economic Case For Prevention, With Deloitte’s Elizabeth Hampson

Drug Fix: WuXi vs. the Pentagon, New Advertising Citations, And FDA Explores The Limits Of AI

【3分で解説  #世界のファーマ】第29回【トランプ関税で注目】米国、医薬品不足のいま (Japanese-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 15, 2026

Scrip's Five Must-Know Things - Jun. 15, 2026

플랙쉽 파이오니어링, 한국서 장기적 파트너십, 바이오 생태계 성장 모색 (Korean-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 8, 2026

Scrip's Five Must-Know Things - June 1, 2026

Scrip's Five Must-Know Things - June 8, 2026

Drug Fix: SCOTUS Rules On Generic Skinny Labels, US FDA’s NPV Faces Uncertain Future

Ambu CEO Britt Meelby Jensen on EU competitivity and compromise

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 1, 2026

Decoding Cell Stress at Soley Therapeutics

Drug Fix: Potential Nondisclosure Agreements For US FDA Staff, Hiring Threatens User Fee Reductions

Scrip's Five Must-Know Things - May 25, 2026

Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 25, 2026

Drug Fix: What’s Next For US FDA After Senior Leadership Purge

MHRA’s Rob Reid updates on timings for CE marking, pre-market SI and possible EU MDR outcomes

Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise

Europe’s Evolving Role in Global Clinical Trials

Scrip Deals Podcast: An Interview With Jeremy Levin

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 18, 2026

Scrip's Five Must-Know Things - May 18, 2026

Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner

ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK

The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals

Kurma’s €215m Fund And What It Says About European Funding Environment

The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview

Podcast: Inside Arcutis with CEO Frank Watanabe

How Agentic AI Could Reshape Consumer Health, With IQVIA’s Volker Spitzer

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 11, 2026

Scrip's Five Must-Know Things - May 11, 2026

Drug Fix: US FDA’s Makary Pressured To Resign, Continues Hiring, Reform Efforts

Forum chief Gwyn Tudor puts the case for medtech development in Wales

Drug Fix: The New Acting US FDA Biologics Center Director, SCOTUS Eyes Generic Drug Policy

Carna Health On Closing the Gap in CKD Prevention

What To Expect After China’s First siRNA Firm Went Public

Five-Minute Podcast: Chris Jones On Wales' Life Sciences Innovation Hub

Cracking China's Consumer Health Market, With QIVA Global's Ellie Adams

Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 27, 2026

Scrip's Five Must-Know Things - Apr. 27, 2026

PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗？(Chinese-language podcast)

Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise

Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roegge.

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 21, 2026

Scrip's Five Must-Know Things - Apr. 21, 2026

The Generics Bulletin Podcast: Green Regulations With Medicines for Europe’s Adrian van den Hoven

Drug Fix: CBER Director Candidate Emerges, US FDA Promotes Leucovorin Pathway

성숙기 진입 중인 ADC 시장…삼성바이오에피스, 차별화 전략 강화 (Korean-language podcast) Apr. 17, 2026

Japan Q1 Roundup: Key Commercial and Policy/Regulatory Developments

Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 10, 2026

Scrip's Five Must-Know Things - Apr. 13, 2026

Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change

No Matter What: How Israel Is Positioning Itself as a Global Pharma Innovation Hub

Inside Step Pharma’s Pan‑Cancer Ambition

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 6, 2026

Scrip's Five Must-Know Things - Apr. 6, 2026

China Biopharma English-Language Podcast: China’s Regulatory Changes In Cell Therapy

Five-Minute Podcast: “UK Needs To Align More With The EU”

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026

Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula

Scrip's Five Must-Know Things - Mar.30, 2026

Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026

Scrip's Five Must-Know Things - Mar.23, 2026

Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes

How a CDMO Created a Custom Vaccine Development Project

뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026

The Generics Bulletin Podcast: 2026 Conferences

Winning In The Probiotics Space, With David Pineda Ereño

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026

Scrip's Five Must-Know Things - Mar.16, 2026

Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?

Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026

Scrip's Five Must-Know Things - Mar.9, 2026

Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs

Unpacking Europe’s Probiotic Rules with David Pineda Ereño

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026

Scrip's Five Must-Know Things - Mar.2, 2026

Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use

Affibody and the Case for Antibody Mimetics in Radioligand Therapy

글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026

Scrip's Five Must-Know Things - Feb.24, 2026

Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues

Hansa Biopharma On Clearing The Path To Kidney Transplant

ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026

Scrip's Five Must-Know Things - Feb.16, 2026

Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions

Preventing Lung Disease in Preterm Babies

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026

Scrip's Five Must-Know Things - Feb. 9, 2026

Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?

Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026

Scrip's Five Must-Know Things - Feb. 2, 2026

Drug Fix: Understanding US FDA’s CNPV Application Reviews

How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.26, 2026

Scrip's Five Must-Know Things - Jan. 26, 2026

Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026

Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?

Herantis’s ‘Elegant’ Approach In Parkinson’s

【3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.19, 2026

Scrip's Five Must-Know Things - Jan. 19, 2026

Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.13, 2026

Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)

Scrip's Five Must-Know Things - Jan. 13, 2026

Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA

Building a Nasal First line of Defense Against H5N1

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Dec. 22, 2025

“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation

Scrip Awards Podcast, 2025 Winners

Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD

Scrip M&A Podcast: PwC's Dealmaking Preview for 2026

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Dec. 15, 2025

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Dec. 8, 2025

Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick

Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle

【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Dec. 1, 2025

글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Nov. 25, 2025

Charles River CSO Calls For Collaboration On Non-Animal Models

Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls

Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences

EY's Arda Ural on IPOs, Financial Markets and Tarrifs

Datamonitor Healthcare Podcast: ESMO 2025

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Nov. 10, 2025

Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center

Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Nov. 4, 2025

Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform

Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine

Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?

국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 27, 2025

Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape

Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

Innovating Autoimmune Treatment with In Vivo CAR-T

How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 20, 2025

Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy

Adalvo: Exploring European B2B Pharma’s Next Steps

Lupus Clinical Development Enters a New Era of Innovation

Essential Pharma – Following A Patient First Philosophy

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 14, 2025

Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases

Defining the Next Era of Disruption

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao

Scrip's Five Must-Know Things - Oct. 6, 2025

Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025

Scrip's Five Must-Know Things - Sept. 30, 2025

The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy

3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025

Scrip's Five Must-Know Things - September 22, 2025

ICROM on Innovation in HPAPI & Crystallization

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025

Scrip's Five Must-Know Things - September 16, 2025

Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report

Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech

Why Local Matters: A Leadership Perspective on Community-Based Trials

From Abandonment To Opportunity In Pediatric Pharma

Scrip's Five Must-Know Things - September 5, 2025

Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten

Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters

China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance

Scrip's Five Must-Know Things - Sept. 1, 2025

Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises

Navigating What’s Next for Global Drug Development: What Sponsors Need to Know

VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)

【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ

How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten

Scrip's Five Must-Know Things - August 25, 2025

Merck KGaA's Vision For Making Digital Health Redundant

Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform

Scrip's Five Must-Know Things - August 15, 2025

Scrip's Five Must-Know Things - August 8, 2025

Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models

Poolbeg CEO On The Biotech’s Big Bet On Small Molecules

Scrip's Five Must-Know Things - August 4, 2025

Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials

The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis

Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

Scrip's Five Must-Know Things - July 28, 2025

Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off

MoonLake Leaders On Its Fast-Track Vision And $500m Deal

Scrip's Five Must-Know Things - July 22, 2025

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized

Strategic Insights into the RNA Market

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules

“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision

Astellas Doubles Down on Gene Therapy Despite Industry Headwinds

Scrip's Five Must-Know Things - July 14, 2025

Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles

Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

Scrip's Five Must-Know Things - July 7, 2025

【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)

ADDF's Karen Harris: Investing in Alzheimer's Like a VC

China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss

Datamonitor Healthcare Podcast: ASCO 2025

Master Regulatory Hurdles and Accelerate Your Drug Development

Scrip's Five Must-Know Things - June 30, 2025

Post-BIO Podcast: Thoughts From The Frontlines

Navigating Regulatory Uncertainty: Diversity Action Plans

How to Crush Competitive Threats and Stand Out in Biotech

Scrip's Five Must-Know Things - June 23, 2025

유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)

Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone

Scrip's Five Must-Know Things - 16 June 2025

Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing

Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)

Strategies to Secure Critical Biotech Funding Amid Market Challenges

How to Survive Innovation Pressure in Today’s Biotech Landscape

Scrip's Five Must-Know Things - 9 June 2025

Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts

A Deep Dive into Sjögren's Disease

Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap

Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative

SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases

Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer

The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025

Podcast: Navigating the Future of Hepatology Clinical Trials

Innovation & Integrity: The Dual Path to Success for Device Makers

Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon

Scrip's Five Must-Know Things - 2 June 2025

Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation

FDA in Transition: How Regulatory Shifts Are Redefining Drug Development

Scrip's Five Must-Know Things - 26 May 2025

Drug Fix: US FDA’s Big Vaccine Policy Week

“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System

제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)

Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

Scrip's Five Must-Know Things - 19 May 2025

China Biopharma Podcast - 14 May 2025 (Chinese language)

Scrip's Five Must-Know Things - 12 May 2025

Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns

Scrip's Five Must-Know Things - 7 May 2025

Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer

OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities

Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

Conference Catch-Up: BIO-Europe 2025

Highlights from AAN 2025

Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs

Scrip's Five Must-Know Things - 28 April 2025

Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval

Precision Medicine in Liver Treatment: The Ochre Bio Approach

Scrip's Five Must-Know Things - 21 April 2025

Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

Scrip's Five Must-Know Things - 14 April 2025

미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)

Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

Scrip's Five Must-Know Things - 7 April 2025

Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact

CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data

Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype

Scrip's Five Must-Know Things - 31 March 2025

Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA

Innovative Oncology, A Conversation with iOnctura

Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”

What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite

Scrip's Five Must-Know Things - 24 March 2025

Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches

Scrip's Five Must-Know Things - 17 March 2025

Drug Fix: Buyouts, Departures and Other US FDA Chaos

Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.

Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025

The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US

Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

Scrip's Five Must-Know Things - 10 March 2025

Grove AI and Grace, An Agentic AI For Clinical Trial Engagement

Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?

【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)

트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)

The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley

Scrip's Five Must-Know Things - 3 March 2025

Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push

Scrip's Five Must-Know Things - 25 February 2025

Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley

Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry

Scrip's Five Must-Know Things - 18 February 2025

Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts

Podcast: JPM Tracked and Unpacked

Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)

Scrip's Five Must-Know Things - 10 February 2025

Getting Creative In Consumer Health, With All Creative’s Beverley Law

Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing

Scrip's Five Must-Know Things

Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration

Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI

Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings

Scrip's Five Must-Know Things - 27 January 2025

Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA

Fauna Bio: Gleaning Therapeutic Insights From Animals

Scrip's Five Must-Know Things - 20 January 2025

Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends

A “Game Changer” For The High-Risk MDS Patient Population

Scrip's Five Must-Know Things - 14 January 2025

Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On

2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)

Pre-JPM Biotech Dealmaking Roundtable

Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push

The Future of Immunotherapy

An Insight into NASH

올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024

Scrip's Five Must-Know Things - 23 December 2024

The Future Of eClinical Technology

The Generics Bulletin Podcast: Highlights Of 2024

Five Must-Know Things - 16 December 2024

The Role of Site Networks & Why They Matter

Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison

Scrip's Five Must-Know Things - 10 December 2024

Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases

Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models

November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology

Treating Rare Diseases With tRNA

Conference Catch-Up: BIO-Europe 2024

Scrip's Five Must-Know Things - 2 December 2024

Scrip Awards Podcast, Ep2: 2024 Awards Preview & Verona Pharma Interview

Drug Fix: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS

Scrip's Five Must-Know Things - 25 November 2024

Scrip's Five Must-Know Things - 18 November 2024

Drug Fix: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?

Scrip M&A Podcast: Why Did Biopharma M&A Metrics Decline During Q2 And Q3

Scrip's Five Must-Know Things - 11 November 2024

Using AI To Predict Our Immune Responses

Conference Catch-Up: Navigating the Evolving CDMO Landscape

Drug Fix: How Will Trump’s Second Term Impact The US FDA?

Digital Health Roundup: GE HealthCare On AI At HLTH; EU AI Act, Click Therapeutics

Scrip's Five Must-Know Things - 5 November 2024

【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)

Scrip's Five Must-Know Things - 28 October 2024

Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)

October 2024 Datamonitor Healthcare Podcast: Insights from ESMO

Scrip's Five Must-Know Things - 21 October 2024

Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI

빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)

China Biopharma Podcast - 16 October 2024 (Chinese language)

Scrip's Five Must-Know Things - 15 October 2024

Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway

Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch

COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky

Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies

Alpha-Synuclein Testing Comes of Age

Q&A Session: PIK3CA Mutations and Breast Cancer

Conference Catch-Up: LSX World Congress USA 2024

The Future Of Drug R&D Is Self-Driving

Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO

Challenges in the Development and Manufacturing of ADCs

September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up

Health-Related Quality of Life Considerations In Clinical Trials

Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care

Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging

September 2024 Datamonitor Healthcare Podcast: Diving into the TME

The Generics Bulletin Podcast: Recent And Upcoming Industry Events

【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)

J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)

Scrip's Five Must-Know Things - 9 September 2024

Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban

Scrip's Five Must-Know Things - 2 September 2024

Drug Fix: New US FDA Developments In AI Regulation

Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart

Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

Scrip's Five Must-Know Things - 26 August 2024

August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics

Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery

Scrip's Five Must-Know Things - 19 August 2024

Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices

【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)

Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge

Scrip's Five Must-Know Things - 13 August 2024

Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld

Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms

Type 2 Diabetes and SGLT2 Inhibitors Q&A

비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)

Scrip's Five Must-Know Things - 5 August 2024

Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes

China Biotech Podcast - 2 August 2024 (Chinese language)

July 2024 Datamonitor Healthcare Podcast: The Future of Biologics in COPD

Q&A Session on the Treatment of Multiple Myeloma

How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten

Scrip's Five Must-Know Things - 29 July 2024

Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push

The Exciting Future of Heart Failure Management

Early Detection Key in COPD Management (Q&A with Brittany Little, NP)

Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance

Scrip's Five Must-Know Things - 22 July 2024

Medtech Connect 16: AI For Cross Border Regulation

Drug Fix Special: Why The US Approves Most New Drugs Before The EU

국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)

The Importance of Exploring Genetic Potential

Scrip's Five Must-Know Things - 16 July 2024

EPR Consultant Urges Producers To Start Collecting Packaging Data

Improving Communication: The Relationship Between Biotech And Biopharma

【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)

Scrip's Five Must-Know Things - 8 July 2024

Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead

Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection

In Vivo Podcast Episode with Stefan Woxström

How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz

Scrip's Five Must-Know Things - 1 July 2024

Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming

China Biotech Podcast - 26 June 2024 (Chinese language)

Scrip's Five Must-Know Things - 24 June 2024

Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB

The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

Scrip's Five Must-Know Things - 17 June 2024

Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond

June 2024 Datamonitor Healthcare Podcast: ASCO 2024

China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)

ASCO 결산: 암 연구의 미래는? (Korean-language podcast)

Scrip's Five Must-Know Things - 10 June 2024

The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents

China Biotech Podcast - 5 June 2024 (Chinese language)

JB CEO On CDMO Growth, Red Sea Crisis And More

Scrip's Five Must-Know Things - 3 June 2024

The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse

How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions

'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation

China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen

Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)

Scrip's Five Must-Know Things - 27 May 2024

Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock

【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast)

Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing

Leading PRO Discusses Plans For Administering State EPR Programs

개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)

How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane

Scrip's Five Must-Know Things - 20 May 2024

Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation

May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma

China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)

Scrip's Five Must-Know Things - 13 May 2024

Episode 15: Digital Trust

Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

Scrip's Five Must-Know Things - 7 May 2024

Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review

Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch

April Datamonitor Podcast 2024: AAN coverage

Scrip's Five Must-Know Things - 30 April 2024

2024 Global Generics & Biosimilars Awards

Podcast: Facilitating Patient Monitoring in CAR-T Development

Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session

China Biotech Podcast - 26 April 2024 (Chinese and English Language)

Future Governance & Oversight of the EU Medtech Regulatory System

Citeline - Cerba Research Podcast V2

Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics

Turning That Frown Upside Down: Treating Depression With Facial Botox Injections

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal

Scrip's Five Must-Know Things - 22 April 2024

Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Next-Generation Diagnostics: "Breathomics" From Imspex

Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets

China Biotech Podcast (Chinese- and English-language) - April 2024

Scrip's Five Must-Know Things - 15 April 2024

Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide

In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef

Scrip's Five Must-Know Things - 8 April 2024

Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA

Medtech Connect Episode 14: Live From HIMSS 2024

피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)

Scrip's Five Must-Know Things - 1 April 2024

Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen

March Datamonitor Podcast 2024: The US Inflation Reduction Act

Scrip's Five Must-Know Things - 26 March 2024

Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC

China Biotech Podcast (Chinese language) - March 2024

Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent

Scrip's Five Must-Know Things - 18 March 2024

How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen

【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)

"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"

Scrip's Five Must-Know Things - 11 March 2024

Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget

Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)

Medtech Connect Episode 13: Augmented Reality In Surgery

Scrip's Five Must-Know Things - 4 March 2024

Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics

The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra

February Datamonitor Podcast: 2024 Clinical Outlook

NodThera On The Role Of The Brain In Driving Chronic Disease

Scrip's Five Must-Know Things - 26 February 2024

Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates

AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana

Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages

China Biotech Podcast (Chinese and English Language) - February 2024

혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)

Trio Of Diagnostics Execs Weigh In On Upcoming Challenges

China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang

Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate

Scrip's Five Must-Know Things - 5 February 2024

Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics

Scrip's Five Must-Know Things - 29 January 2024

Medtech Connect Episode 12: Apple’s Patent Infringement Cases

Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety

Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD

The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate

Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)

【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)

Scrip's Five Must-Know Things - 15 January 2024

Pennine Health Talks Sustainability Compliance and ESG Initiatives

Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI

Building A Biotech: Exploring ILC’s Hybrid Interferon Platform

전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)

Scrip's Five Must-Know Things - 10 January 2024

Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions

China Biotech Podcast - January 2024 (Chinese-language)

Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon

Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation

Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!

The Challenges of Rare Neurological Disease Drug Development

【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)

Medtech Connect Episode 11: A Look Back At 2023

Biopharma’s Must-Know 2023-4 Catalysts

Scrip’s Five Must-Know Things – 19 December 2023

Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis

China Biotech Podcast - December 2023 (Chinese-language)

Scrip’s Five Must-Know Things – 11 December 2023

Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision

제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)

Scrip's Five Must-Know Things - 4 December 2023

Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA

RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering

Scrip’s Five Must-Know Things – 27 November 2023

Trends In Epidemiology

Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech

China Biotech Podcast (Chinese language) - November 2023

Discussing The Potentials Of And Challenges For Digital Therapeutics

Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology

Scrip’s Five Must-Know Things – 20 November 2023

Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy